Lisata Therapeutics Inc (LSTA)

[akasidney86]

Now's the time, as there's a real convergence of work going on that will push stem cell and immunotherapy into the mainstream. Yahoo even had extensive news yesterday about immunotherapies, which puts a long way from the battles around Provenge. This is today's pressy from CLBS:

BASKING RIDGE, N.J., Apr. 20, 2016 – Caladrius Biosciences, Inc. (NASDAQ: CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development and manufacturing services provider (PCT) with a select therapeutic development pipeline, announces today that Company’s Chief Medical Officer, Dr. Douglas Losordo, will present at multiple conferences in the month of April with a primary focus on the company’s T regulatory cell program for type 1 diabetes.

GTC Diabetes Summit 2016
Website: https://www.gtcbio.com/conferences/diabetes-summit-overview
Venue: Hyatt Regency, Boston, MA
Session 1
Date and Time: Monday, April 25, 2016, 4:30 PM ET
Presenter: Dr. Douglas Losordo, Senior Vice President, Clinical, Medical and Regulatory Affairs and Chief Medical Officer
Topic: Autologous Polyclonal Ex-Vivo Expanded Treg Therapy for New Onset Type 1 Diabetes in Children
Session 2
Date and Time: Tuesday, April 26, 2016, 1:45 PM ET
Panelist: Dr. Douglas Losordo
Topic: Models for Successful Partnerships Among Academia, Government, and Industry
GTC Stem Cell Summit 2016
Date and Time: Wednesday, April 27, 2016, 9:15 AM ET
Website: https://www.gtcbio.com/conferences/stem-cell-product-development-commercialization-agenda
Venue: Hyatt Regency, Boston, MA
Presenter: Dr. Douglas Losordo
Topic: Stem Cell Product Development and Commercialization: Challenges in Clinical Efficacy | Autologous CD34 Cell Therapy for Treatment of Cardiovascular Disease. Eight positive clinical trials: Where do we go from here?
Third International Regenerative Medicine Conference 2016
Date and Time: Thursday, April 28, 2016, 4:50 PM CET
Website: http://celltherapyconference2016.com/
Venue: The Vatican, Vatican City
Panelist: Dr. Douglas Losordo
Topic: Cell Therapy Research Discussion for Type 1 Diabetes

Let's keep fingers crossed that they can hit one of these out of the park while the manufacturing pays the bills.